DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 189 filers reported holding DICERNA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $59,712,000 | +191.9% | 1,600,000 | +100.0% | 0.39% | +49.8% |
| Q1 2021 | $20,456,000 | +16.1% | 800,000 | 0.0% | 0.26% | +37.0% |
| Q4 2020 | $17,624,000 | +22.5% | 800,000 | 0.0% | 0.19% | -10.0% |
| Q3 2020 | $14,392,000 | -29.2% | 800,000 | 0.0% | 0.21% | -36.2% |
| Q2 2020 | $20,320,000 | +2427.4% | 800,000 | +2092.0% | 0.33% | +1956.2% |
| Q4 2019 | $804,000 | +200.0% | 36,496 | -27.0% | 0.02% | -33.3% |
| Q1 2016 | $268,000 | -54.9% | 50,000 | 0.0% | 0.02% | -45.5% |
| Q4 2015 | $594,000 | -27.7% | 50,000 | -50.0% | 0.04% | +33.3% |
| Q3 2015 | $822,000 | +17.8% | 100,000 | +100.0% | 0.03% | -21.4% |
| Q2 2015 | $698,000 | – | 50,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 2,062,991 | $7,014,000 | 1.85% |
| RA Capital Management | 2,428,571 | $8,257,000 | 1.01% |
| Omega Fund Management, LLC | 223,457 | $760,000 | 0.49% |
| 683 Capital Management, LLC | 800,000 | $2,720,000 | 0.42% |
| EcoR1 Capital, LLC | 382,000 | $1,299,000 | 0.33% |
| Eventide Asset Management | 377,000 | $1,282,000 | 0.08% |
| Palo Alto Investors LP | 481,519 | $1,637,000 | 0.08% |
| SABBY MANAGEMENT, LLC | 200,000 | $680,000 | 0.04% |
| BOURGEON CAPITAL MANAGEMENT LLC | 13,500 | $46,000 | 0.03% |
| Quotient Investors, LLC | 13,600 | $46,000 | 0.03% |